SC 13G Filing

Company

Edgewise Therapeutics, Inc.

Filed

May 18, 2021

Accession Number

0000929638-21-000716

A Schedule 13G is filed when a passive investor acquires more than 5% of a company's shares without intent to influence control. Learn more about SC 13G filings →